» Articles » PMID: 38632391

The Fasciola Cinereum of the Hippocampal Tail As an Interventional Target in Epilepsy

Overview
Journal Nat Med
Date 2024 Apr 17
PMID 38632391
Authors
Affiliations
Soon will be listed here.
Abstract

Targeted tissue ablation involving the anterior hippocampus is the standard of care for patients with drug-resistant mesial temporal lobe epilepsy. However, a substantial proportion continues to suffer from seizures even after surgery. We identified the fasciola cinereum (FC) neurons of the posterior hippocampal tail as an important seizure node in both mice and humans with epilepsy. Genetically defined FC neurons were highly active during spontaneous seizures in epileptic mice, and closed-loop optogenetic inhibition of these neurons potently reduced seizure duration. Furthermore, we specifically targeted and found the prominent involvement of FC during seizures in a cohort of six patients with epilepsy. In particular, targeted lesioning of the FC in a patient reduced the seizure burden present after ablation of anterior mesial temporal structures. Thus, the FC may be a promising interventional target in epilepsy.

Citing Articles

A Tail Yet to be Told: The Fasciola Cinereum in Epilepsy.

Yaser S, Danzer S Epilepsy Curr. 2025; 15357597241309175.

PMID: 39845192 PMC: 11748303. DOI: 10.1177/15357597241309175.


On-Demand Seizures Facilitate Rapid Screening of Therapeutics for Epilepsy.

Chen Y, Litt B, Vitale F, Takano H bioRxiv. 2024; .

PMID: 39464023 PMC: 11507747. DOI: 10.1101/2024.08.26.609726.


Epilepsy insights revealed by intravital functional optical imaging.

Stern M, Dingledine R, Gross R, Berglund K Front Neurol. 2024; 15:1465232.

PMID: 39268067 PMC: 11390408. DOI: 10.3389/fneur.2024.1465232.

References
1.
McGinn R, Von Stein E, Summers Stromberg J, Li Y . Precision medicine in epilepsy. Prog Mol Biol Transl Sci. 2022; 190(1):147-188. DOI: 10.1016/bs.pmbts.2022.04.001. View

2.
Wendling A, Hirsch E, Wisniewski I, Davanture C, Ofer I, Zentner J . Selective amygdalohippocampectomy versus standard temporal lobectomy in patients with mesial temporal lobe epilepsy and unilateral hippocampal sclerosis. Epilepsy Res. 2012; 104(1-2):94-104. DOI: 10.1016/j.eplepsyres.2012.09.007. View

3.
Schramm J . Temporal lobe epilepsy surgery and the quest for optimal extent of resection: a review. Epilepsia. 2008; 49(8):1296-307. DOI: 10.1111/j.1528-1167.2008.01604.x. View

4.
Schramm J, Lehmann T, Zentner J, Mueller C, Scorzin J, Fimmers R . Randomized controlled trial of 2.5-cm versus 3.5-cm mesial temporal resection in temporal lobe epilepsy--Part 1: intent-to-treat analysis. Acta Neurochir (Wien). 2010; 153(2):209-19. DOI: 10.1007/s00701-010-0900-6. View

5.
Haegelen C, Perucca P, Chatillon C, Andrade-Valenca L, Zelmann R, Jacobs J . High-frequency oscillations, extent of surgical resection, and surgical outcome in drug-resistant focal epilepsy. Epilepsia. 2013; 54(5):848-57. PMC: 3712982. DOI: 10.1111/epi.12075. View